Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW) -- Ignore unavailable to you. Want to Upgrade?

To: JEFF CHAPMAN who wrote (305)	5/20/1998 4:44:00 PM
From: Gerald Underwood	Read Replies (1) \| Respond to of 705

Jeff, IMO, the wisest thing to do is for each investor to make his own decision based on his own DD. With this rapid increase there is certainly going to be games and day trading going on tomorrow and the next and the next and so on. The one thing we must keep our sights on is that projected phase II testing appears to not require a prolonged period of time. About 8 weeks for testing and observation I believe. Give another 4 weeks for appraisal and it is very possible we could be given results on this portion of phase II within a quarter. This is a very short wait for the kind of pay off this stock is capable of. Believe me I will be tempted, but I have held NEO for a year now and don't plan to give my stock away cheap. The stock could just as well progress like it did last year on a new plateau. It is not uncommon for phase II stocks with a lot of initial promise and excellent phase I results to apply for and obtain accelerated approval from FDA with successful phase II results. With NIH and other agencies involved with these tests, the credibility of NEO's results are just that much enhanced. IMHO. Gerry